212Pb-conjugated anti-rat HER2/neu antibody against a neu-N derived murine mammary carcinoma cell line: cell kill and RBE in vitro
Author:
Affiliation:
1. Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
2. Department of Radiation Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
3. ORANO Med, Plano, TX, USA
Funder
National Cancer Institute
Publisher
Informa UK Limited
Subject
Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09553002.2022.2033341
Reference49 articles.
1. Recent developments in Geant4
2. Biological Effect of Lead-212 Localized in the Nucleus of Mammalian Cells: Role of Recoil Energy in the Radiotoxicity of Internal Alpha-Particle Emitters
3. Methodology for labeling proteins and peptides with lead-212 (212Pb)
4. Alpha-Particle Emitting Atomic Generator (Actinium-225)-Labeled Trastuzumab (Herceptin) Targeting of Breast Cancer Spheroids
5. Preclinical Evaluation of 203/212Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of HER2-Targeted Intraperitoneal225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis;Journal of Nuclear Medicine;2023-06-22
2. Large-scale in vitro microdosimetry via live cell microscopy imaging: implications for radiosensitivity and RBE evaluations in alpha-emitter radiopharmaceutical therapy;Journal of Translational Medicine;2023-02-24
3. Correction;International Journal of Radiation Biology;2023-02-21
4. Bone Marrow Relative Biological Effectiveness for a 212Pb-labeled Anti-HER2/neu Antibody;International Journal of Radiation Oncology*Biology*Physics;2023-02
5. Dosimetry of [212Pb]VMT01, a MC1R-Targeted Alpha Therapeutic Compound, and Effect of Free 208Tl on Tissue Absorbed Doses;Molecules;2022-09-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3